Ass.Prof. Mag. Andrea De Luna, PhD

Danube University Krems

Andrea De Luna

Ass.Prof. Mag. Andrea De Luna, PhD

Center for Regenerative Medicine

Projects (Extract Research Database)

Publications (Extract Research Database)

De Luna-Preitschopf, A.; Zwickl, H.; Nehrer, S.; Hengstschläger, M.; Mikula, M. (2017). Rapamycin Maintains the Chondrocytic Phenotype and Interferes with Inflammatory Cytokine Induced Processes. International Journal of Molecular Sciences, 18(7): doi:10.3390/ijms18071494

Kuten, O.; Simon, M.; Hornyák, I.; De Luna-Preitschopf, A.; Nehrer, S.; Lacza, Z. (2017). The Effects of Hyperacute Serum on Adipogenesis and Cell Proliferation of Mesenchymal Stromal Cells. Tissue Engineering Part A, Vol. 24, No. 11-12: doi: 10.1089/ten.TEA.2017.0384

Preitschopf, A.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Zwickl, H.; Rosner, M.; Joó, J.G.; Nehrer, S; Hengstschläger, M; Mikula, M. (2016). Rapamycin-Induced Hypoxia Inducible Factor 2A Is Essential for Chondrogenic Differentiation of Amniotic Fluid Stem Cells. Stem Cells Translational Medicine: 580-90

Schörghofer, D.; Kinslechner, K.; Preitschopf, A.; Schütz, B.; Röhrl, C.; Hengstschläger, M.; Stangl, H.; Mikula, M. (2015). The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence. Reprod Biol Endocrinol, Vol. 13, No. 88

Üstün, S.; Lassnig, C.; Preitschopf, A.; Mikula, M.; Müller, M.; Hengstschläger, M.; Weichhart, T. (2015). Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models. Transplantation Immunology: 45-50

Üstün, S.; Lassnig, C.; Preitschopf, A.; Mikula, M.; Müller, M.; Hengstschläger, M.; Weichhart, T. (2015). Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models. Transpl Immunol.

Preitschopf, A.; Zwickl, H.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Rosner, M.; Joo, G.J.; Hengstschläger, M.; Nehrer, S.; Mikula, M. (2015). Rapamycin enhances Sox9 Expression during Chondrogenic Differentiation of Amniotic Fluid Stem Cells. Tissue Engineering Part A, September 2015, Volume 21, Supplement 1: 192

Preitschopf, A.; Zwickl, H.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Rosner, M.; Joó, J.; Hengstschläger, M.; Nehrer, S.; Mikula, M. (2015). Rapamycin enhances SOX9 expression during chondrogenic differentiation of amniotic fluid stem cells. Tissue Engineering Part A: 192-93

Preitschopf, A.; Li, K.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Thi Thanh Pham, H.; Rosner, M.; Joo, G.; Röhrl, C.; Weichhart, T.; Stangl, H.; Lubec, G.; Hengstschläger, M.; Mikula, M. (2014). mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression. Plos One

Preitschopf, A.; Busch, J.; Zwickl, H.; Nehrer, S.; Hengstschläger, M.; Mikula, M. (2014). Amniotic Fluid Stem Cells for the Treatment of Articular Cartilage Defects. In: Perinatal Stem Cells: 87-98, Springer Verlag

Load more
from

Lectures (Extract Research Database)

Different production technology of blood derived products influences differentiation pathway of various cell populations

World Congress of the International Society of Tissue Engineering and Regenerative Medicine (TERMIS), Kyoto, Japan, 07/09/2018

Different production technology of blood derived products influences differentiation pathway of various cell populations

Gordon Research Conference on Extracellular Vesicles, Newry, USA, 21/08/2018

Different production technology of blood derived products influences differentiation pathway of various cell populations

14. World congress of the International cartilage repair society (ICRS) , Macau, China, 12/04/2018

Inhibierung des mTORC1 Signalweges erhält den chondrogenen Phönotyp von OA Chondrozyten

32. Jahreskongress der GOTS, 24/06/2017

Rapamycin preserves the chondrogenic phenotype and supresses cartilage degrading and inflammatory processes in Osteoarthritis

OARSI 2017 World Congress, 28/04/2017

Strategies for Cartilage Regeneration

14. International Life Science Meeting Krems, 05/04/2017

Rapamycin-Induced Hypoxia Inducible Factor 2A Is Essential for Chondrogenic Differentiation of Amniotic Fluid Stem Cells

Osteoarthritis Research Society International World Congress - Amsterdam, Netherlands, 01/04/2016

The role of the mTOR pathway on the chondrogenic differentiation of human amniotic fluid stem cells

Österreichische Gesellschaft für Orthopädie - Vienna,Austria, 30/10/2015

The role of the mTOR pathway on the chondrogenic differentiation of human amniotic fluid stem cells

Tissue Engineering and regenerative Medicine International Society World Kongress - Boston, USA, 11/09/2015

Rapamycin enhances Sox9 expression during chondrogenic differentiation of amniotic fluid stem cells

4th TERMIS World Congress, Boston, USA, 08/09/2015

Load more
from
Back to top

 

To Glossary

This website uses cookies to improve your user experience and for analytical purposes for optimizing our systems. By clicking on „OK" or continuing to browse the site, you are agreeing to the use of cookies. More information concerning privacy policy and data protection official.

OK